Somerset Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78M Sell
48,273
-250
-0.5% -$20.2K 1.07% 32
2026
Q1
$4.2M Sell
48,523
-1,014
-2% -$97.1K 1.29% 26
2025
Q4
$4.76M Buy
49,537
+288
+0.6% +$28K 1.46% 25
2025
Q3
$4.69M Buy
49,249
+422
+0.9% +$38.8K 1.45% 26
2025
Q2
$4.26M Buy
48,827
+68
+0.1% +$5.77K 1.39% 27
2025
Q1
$4.38M Buy
48,759
+3,394
+7% +$304K 1.56% 23
2024
Q4
$3.62M Sell
45,365
-477
-1% -$41.3K 1.36% 28
2024
Q3
$4.13M Sell
45,842
-2,042
-4% -$172K 1.54% 23
2024
Q2
$3.77M Buy
47,884
+99
+0.2% +$8.12K 1.55% 23
2024
Q1
$4.16M Buy
47,785
+917
+2% +$78.3K 1.7% 20
2023
Q4
$3.86M Sell
46,868
-957
-2% -$72.9K 1.69% 19
2023
Q3
$3.75M Sell
47,825
-630
-1% -$52.7K 1.71% 20
2023
Q2
$4.27M Sell
48,455
-1,924
-4% -$166K 1.84% 16
2023
Q1
$4.06M Sell
50,379
-1,759
-3% -$143K 1.76% 16
2022
Q4
$4.05M Sell
52,138
-1,856
-3% -$150K 1.7% 18
2022
Q3
$4.36M Buy
53,994
+258
+0.5% +$23.2K 2.03% 11
2022
Q2
$4.82M Buy
53,736
+322
+0.6% +$32.6K 2.11% 7
2022
Q1
$5.93M Sell
53,414
-624
-1% -$65.9K 2.29% 7
2021
Q4
$5.59M Buy
54,038
+1,023
+2% +$118K 2.04% 10
2021
Q3
$6.64M Sell
53,015
-350
-0.7% -$45.3K 2.71% 6
2021
Q2
$6.62M Sell
53,365
-92
-0.2% -$11.6K 2.7% 5
2021
Q1
$6.32M Buy
53,457
+286
+0.5% +$33.5K 2.72% 6
2020
Q4
$6.23M Sell
53,171
-593
-1% -$65.3K 2.83% 5
2020
Q3
$5.59M Buy
53,764
+743
+1% +$74.6K 2.81% 6
2020
Q2
$4.86M Buy
53,021
+1,074
+2% +$103K 2.59% 8
2020
Q1
$4.68M Sell
51,947
-861
-2% -$91.6K 3.07% 4
2019
Q4
$5.99M Buy
52,808
+113
+0.2% +$12.4K 2.96% 3
2019
Q3
$5.72M Sell
52,695
-1,704
-3% -$178K 3.02% 2
2019
Q2
$5.3M Buy
54,399
+170
+0.3% +$15.5K 2.73% 3
2019
Q1
$4.94M Buy
54,229
+187
+0.3% +$16.7K 2.6% 4
2018
Q4
$4.92M Buy
54,042
+331
+0.6% +$30.9K 2.86% 3
2018
Q3
$5.28M Buy
53,711
+565
+1% +$52.2K 2.61% 4
2018
Q2
$4.55M Sell
53,146
-1,753
-3% -$146K 2.44% 5
2018
Q1
$4.4M Sell
54,899
-151
-0.3% -$12.5K 2.28% 8
2017
Q4
$4.45M Sell
55,050
-2,492
-4% -$200K 2.22% 8
2017
Q3
$4.47M Sell
57,542
-1,981
-3% -$164K 2.37% 3
2017
Q2
$5.28M Buy
59,523
+2,201
+4% +$186K 2.88% 2
2017
Q1
$4.62M Buy
57,322
+14,001
+32% +$1.09M 2.59% 3
2016
Q4
$3.08M Sell
43,321
-2,610
-6% -$205K 1.83% 9
2016
Q3
$3.97M Buy
45,931
+400
+0.9% +$34.9K 2.36% 4
2016
Q2
$3.95M Buy
45,531
+5,845
+15% +$473K 2.44% 3
2016
Q1
$2.98M Buy
39,686
+291
+0.7% +$21.9K 1.97% 4
2015
Q4
$3.03M Buy
39,395
+474
+1% +$35.7K 1.99% 5
2015
Q3
$2.61M Buy
38,921
+12,627
+48% +$930K 1.83% 6
2015
Q2
$1.95M Buy
26,294
+10,076
+62% +$770K 1.28% 20
2015
Q1
$1.26M Buy
16,218
+1,179
+8% +$89.4K 0.83% 42
2014
Q4
$1.09M Buy
15,039
+409
+3% +$28.4K 0.72% 45
2014
Q3
$907K Buy
14,630
+380
+3% +$24.2K 0.63% 55
2014
Q2
$908K Buy
14,250
+1,060
+8% +$64.4K 0.64% 51
2014
Q1
$812K Buy
13,190
+630
+5% +$36.7K 0.62% 52
2013
Q4
$721K Buy
+12,560
New +$712K 0.55% 56

Other funds holding MDT

Somerset Trust's MDT Position: Q2 2026 in Review

Somerset Trust reduced its Medtronic (MDT) stake by 0.52% in Q2 2026, selling an estimated $20.2K and leaving 48,273 shares worth $3.78M. The position accounts for 1.07% of the portfolio, ranked #32.

Somerset Trust first reported a position in MDT in Q4 2013 and has held it in 51 quarters since. The position peaked at $6.64M in Q3 2021. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Somerset Trust held 48,273 shares of Medtronic worth $3.78M as of Q2 2026.
  • Somerset Trust sold 250 Medtronic shares in Q2 2026, an estimated $20.2K.
  • Medtronic made up 1.07% of Somerset Trust's portfolio in Q2 2026, its #32 holding.
  • Somerset Trust first reported a position in Medtronic in Q4 2013 and has held it in 51 quarters since.
  • Somerset Trust's Medtronic position peaked at $6.64M in Q3 2021.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Somerset Trust's 13F filing for Q2 2026, filed 6 Jul 2026.